Reversal of diastolic dysfunction by intravenous magnesium chloride.
To treat diastolic dysfunction in patients with coronary artery disease (CAD). Open study of the intravenous injection of 5 mL of a solution containing 17% magnesium chloride (equal to 100 mg of elemental magnesium) during routine coronary angiography in patients with a raised left ventricular end-diastolic pressure (LVEDP). A hospital department of cardiac hemodynamics. Ten patients with angiographically documented CAD. After magnesium chloride injection, the LVEDP was significantly reduced in all patients, from a mean of 24 +/- 3 to 16 +/- 3 mmHg (P < 0.001). Under the short term conditions of the study, the injection of magnesium chloride effectively improved left ventricular diastolic function. Further study of the long term effect is required.